Delayed treatment effects, treatment switching and heterogeneous patient populations: How to design and analyze RCTs in oncology

From MaRDI portal
Publication:108613

DOI10.1002/PST.2062WikidataQ98647497 ScholiaQ98647497MaRDI QIDQ108613

Martin Posch, Robin Ristl, Armin Schüler, Heiko Götte, Nicolás M. Ballarini

Publication date: 23 August 2020

Published in: Pharmaceutical Statistics (Search for Journal in Brave)




Related Items (1)







This page was built for publication: Delayed treatment effects, treatment switching and heterogeneous patient populations: How to design and analyze RCTs in oncology